During episode #41 of “The Weekly Bioanalysis”, Dom and John discuss the often sensitive topic of the need for regulation and oversight within the pharma and biopharma industries during testing, manufacturing and clinical trials. The evidence for these things has been made clear many times over the years, but even within the past few weeks, there have been news stories that continue to showcase the importance of having systems in place that ensure all parties involved are following proper and safe procedures that can be monitored and verified.